ACTIVITY AND RESISTANCE GENOMICS OF CEFIDEROCOL IN SEQUENTIAL CHRONIC PSEUDOMONAS AERUGINOSA ISOLATES FROM CYSTIC FIBROSIS PATIENTS
收藏NIAID Data Ecosystem2026-03-14 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/ERP139906
下载链接
链接失效反馈官方服务：
资源简介：
Cefiderocol is a new siderophore cephalosporin approved for the treatment of infections by MDR Gram-negative bacteria, but data on its activity in the CF setting is still limited. Thus, the objective was to evaluate the activity of cefiderocol against P. aeruginosa isolates from chronically-colonized CF patients, as well as to investigate the potential mechanisms involved in resistance.
创建时间：
2022-11-16
